These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37060240)

  • 1. Application of Artificial Intelligence to In Vitro Tumor Modeling and Characterization of the Tumor Microenvironment.
    Lee RY; Wu Y; Goh D; Tan V; Ng CW; Lim JCT; Lau MC; Yeong JPS
    Adv Healthc Mater; 2023 Jun; 12(14):e2202457. PubMed ID: 37060240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning and Artificial Intelligence-driven Spatial Analysis of the Tumor Immune Microenvironment in Pathology Slides.
    Xu H; Cong F; Hwang TH
    Eur Urol Focus; 2021 Jul; 7(4):706-709. PubMed ID: 34353733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response.
    Fu X; Sahai E; Wilkins A
    J Pathol; 2023 Aug; 260(5):578-591. PubMed ID: 37551703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.
    Fetah KL; DiPardo BJ; Kongadzem EM; Tomlinson JS; Elzagheid A; Elmusrati M; Khademhosseini A; Ashammakhi N
    Small; 2019 Dec; 15(50):e1901985. PubMed ID: 31724305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Utilizing Artificial Intelligence in Lab on a Chip for Diagnosis and Treatment.
    Zare Harofte S; Soltani M; Siavashy S; Raahemifar K
    Small; 2022 Oct; 18(42):e2203169. PubMed ID: 36026569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence: illuminating the depths of the tumor microenvironment.
    Xie T; Huang A; Yan H; Ju X; Xiang L; Yuan J
    J Transl Med; 2024 Aug; 22(1):799. PubMed ID: 39210368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Applications of Artificial Intelligence in Neuro-Oncology.
    Rudie JD; Rauschecker AM; Bryan RN; Davatzikos C; Mohan S
    Radiology; 2019 Mar; 290(3):607-618. PubMed ID: 30667332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review.
    Xu H; Cheng C; Le W
    Electrophoresis; 2022 Apr; 43(7-8):839-847. PubMed ID: 35179796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence in Cancer Research and Precision Medicine.
    Bhinder B; Gilvary C; Madhukar NS; Elemento O
    Cancer Discov; 2021 Apr; 11(4):900-915. PubMed ID: 33811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of spatial transcriptomics and artificial intelligence to develop integrated management of pancreatic cancer.
    Maurya R; Chug I; Vudatha V; Palma AM
    Adv Cancer Res; 2024; 163():107-136. PubMed ID: 39271261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging advances in immunopathology and artificial intelligence to analyze in vitro tumor models in composition and space.
    Leong TKM; Lo WS; Lee WEZ; Tan B; Lee XZ; Lee LWJN; Lee JJ; Suresh N; Loo LH; Szu E; Yeong J
    Adv Drug Deliv Rev; 2021 Oct; 177():113959. PubMed ID: 34481035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in three-dimensional tumor models for colorectal cancer].
    Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in technology for characterizing the tumor immune microenvironment.
    Yan H; Ju X; Huang A; Yuan J
    Int J Biol Sci; 2024; 20(6):2151-2167. PubMed ID: 38617534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
    Dzobo K; Adotey S; Thomford NE; Dzobo W
    OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials for Mimicking and Modelling Tumor Microenvironment.
    Das R; Fernandez JG
    Adv Exp Med Biol; 2022; 1379():139-170. PubMed ID: 35760991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer.
    Bueschbell B; Caniceiro AB; Suzano PMS; Machuqueiro M; Rosário-Ferreira N; Moreira IS
    Drug Resist Updat; 2022 Jan; 60():100811. PubMed ID: 35121338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utopia versus dystopia: Professional perspectives on the impact of healthcare artificial intelligence on clinical roles and skills.
    Aquino YSJ; Rogers WA; Braunack-Mayer A; Frazer H; Win KT; Houssami N; Degeling C; Semsarian C; Carter SM
    Int J Med Inform; 2023 Jan; 169():104903. PubMed ID: 36343512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Microenvironment and the Role of Artificial Intelligence in Breast Cancer Detection and Prognosis.
    Malherbe K
    Am J Pathol; 2021 Aug; 191(8):1364-1373. PubMed ID: 33639101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.